초록 ▼

The use of aryloxycarboxylic acid derivatives for the production of a medicament against dermatological diseases especially for combatting ulcus cruris, striae distense atrophicae, cellulitis, collagenoses (lupus erythematosus, sclerodermia, dermatomyositis etc.), REM-syndrome (reticular erythematus

The use of aryloxycarboxylic acid derivatives for the production of a medicament against dermatological diseases especially for combatting ulcus cruris, striae distense atrophicae, cellulitis, collagenoses (lupus erythematosus, sclerodermia, dermatomyositis etc.), REM-syndrome (reticular erythematus-syndrome), alopecia mucinosa, necrobiosis lipoidica diabeticorum, paniculitis nodosa, folliculitis decalvans, psoriasis vulgaris, elastosis senilis, disorders and diseases of elastic fibers, and mesenchymal tumors, collagenous and vascular diseases of the kidneys, liver and lungs, muscle diseases, mesenchymal tumors, burns, cicatrix, lichen sclerosus and atrophicans, anetodermiae (atrophiae cutis), immunological diseases, etc. and as an antagonist against corticosteroids is described.

대표청구항 ▼

A method for treating a dermatological disease selected from the group consisting of striae distense, ulcus cruris, cellulitis, psoriasis, folliculitis decalvans, alopecia mucinosa, necrobiosis lipoidica diabeticorum and mesenchymal tumors which comprises topically, parenteral, subcutaneously or int

A method for treating a dermatological disease selected from the group consisting of striae distense, ulcus cruris, cellulitis, psoriasis, folliculitis decalvans, alopecia mucinosa, necrobiosis lipoidica diabeticorum and mesenchymal tumors which comprises topically, parenteral, subcutaneously or intrarectally administering to a patient a dermatological disease treating effect amount of an aryloxycarboxylic acid derivative selected from the group consisting of [Figure] and [Figure]